Clinical trial
Effect of Insulin Resistance Reducing Agents Pre and Post CABG on Post-operative Metabolic Status and Oxidative Stress
NCT02184507 is registered in ClinicalTrials.gov with Mohammad Hassan Eftekhari as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Insulin Resistance Reducing Agents Pre and Post CABG on Post-operative Metabolic Status and Oxidative Stress
- Lead sponsor
- Mohammad Hassan Eftekhari
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- July 31, 2014
- Enrollment
- 92 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.